Tandem Diabetes Care (TNDM) PT Raised to $59 at Canaccord Genuity
Tweet Send to a Friend
(Updated - May 1, 2025 7:24 AM EDT)
Canaccord Genuity analyst William Plovanic raised the price target on Tandem ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst William Plovanic raised the price target on Tandem ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
